Envestnet Asset Management Inc. trimmed its holdings in shares of The Sherwin-Williams Company (NYSE:SHW - Free Report) by 1.8% during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,062,385 shares of the specialty chemicals company's stock after selling 19,183 shares during the quarter. Envestnet Asset Management Inc. owned 0.42% of Sherwin-Williams worth $370,974,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in SHW. Norges Bank acquired a new stake in Sherwin-Williams during the 4th quarter worth about $1,359,747,000. GAMMA Investing LLC lifted its position in Sherwin-Williams by 41,717.1% during the 1st quarter. GAMMA Investing LLC now owns 1,636,304 shares of the specialty chemicals company's stock worth $571,381,000 after acquiring an additional 1,632,391 shares during the period. Capital Research Global Investors lifted its position in Sherwin-Williams by 47.1% during the 4th quarter. Capital Research Global Investors now owns 2,998,647 shares of the specialty chemicals company's stock worth $1,019,329,000 after acquiring an additional 960,724 shares during the period. Barclays PLC lifted its holdings in shares of Sherwin-Williams by 54.2% in the 4th quarter. Barclays PLC now owns 2,073,533 shares of the specialty chemicals company's stock valued at $704,855,000 after buying an additional 728,798 shares during the period. Finally, Northern Trust Corp lifted its holdings in shares of Sherwin-Williams by 28.0% in the 4th quarter. Northern Trust Corp now owns 2,725,827 shares of the specialty chemicals company's stock valued at $926,590,000 after buying an additional 595,586 shares during the period. 77.67% of the stock is currently owned by hedge funds and other institutional investors.
Sherwin-Williams Stock Performance
SHW traded up $1.89 on Thursday, hitting $353.43. 673,645 shares of the company's stock were exchanged, compared to its average volume of 1,746,206. The stock has a fifty day moving average of $351.43 and a two-hundred day moving average of $347.96. The Sherwin-Williams Company has a twelve month low of $306.63 and a twelve month high of $400.42. The firm has a market cap of $88.57 billion, a PE ratio of 33.41, a P/E/G ratio of 3.11 and a beta of 1.18. The company has a current ratio of 0.77, a quick ratio of 0.45 and a debt-to-equity ratio of 1.90.
Sherwin-Williams (NYSE:SHW - Get Free Report) last released its quarterly earnings results on Tuesday, April 29th. The specialty chemicals company reported $2.25 earnings per share for the quarter, beating analysts' consensus estimates of $2.23 by $0.02. Sherwin-Williams had a return on equity of 71.86% and a net margin of 11.63%. The company had revenue of $5.31 billion for the quarter, compared to analysts' expectations of $5.42 billion. During the same quarter in the previous year, the company posted $2.17 earnings per share. The business's revenue for the quarter was down 1.1% compared to the same quarter last year. On average, research analysts anticipate that The Sherwin-Williams Company will post 12 earnings per share for the current fiscal year.
Sherwin-Williams Dividend Announcement
The firm also recently announced a quarterly dividend, which was paid on Friday, June 6th. Investors of record on Friday, May 16th were issued a dividend of $0.79 per share. This represents a $3.16 dividend on an annualized basis and a yield of 0.89%. The ex-dividend date was Friday, May 16th. Sherwin-Williams's payout ratio is 29.87%.
Wall Street Analysts Forecast Growth
Several equities analysts have recently issued reports on the company. Royal Bank Of Canada boosted their price objective on Sherwin-Williams from $410.00 to $420.00 and gave the company an "outperform" rating in a report on Thursday, May 1st. Barclays reduced their price target on Sherwin-Williams from $385.00 to $355.00 and set an "equal weight" rating for the company in a report on Tuesday, April 1st. Bank of America boosted their price objective on Sherwin-Williams from $289.00 to $296.00 and gave the stock an "underperform" rating in a research note on Monday, June 23rd. Citigroup lowered Sherwin-Williams from a "buy" rating to a "neutral" rating and cut their price objective for the stock from $405.00 to $385.00 in a research note on Friday, June 13th. Finally, Wells Fargo & Company upgraded Sherwin-Williams from an "equal weight" rating to an "overweight" rating and boosted their price objective for the stock from $350.00 to $420.00 in a research note on Wednesday, April 30th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, ten have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and an average target price of $391.94.
View Our Latest Report on Sherwin-Williams
About Sherwin-Williams
(
Free Report)
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Featured Articles

Before you consider Sherwin-Williams, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sherwin-Williams wasn't on the list.
While Sherwin-Williams currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.